
The brand name of the drug is Parsabiv. The active ingredient is etelcalcetide, which is a synthetic peptide calcium-sensing receptor agonist, and is provided in the form of its hydrochloride salt. Parsabiv is formulated as an injection in a single-dose vial, available in 2.5 mg, 5 mg, and 10 mg dosage strengths for intravenous use. Key inactive ingredients include sodium chloride and succinic acid. It is designed for sterile and preservative-free administration.